跳至主要内容
临床试验/DRKS00029665
DRKS00029665尚未招募不适用

OBJECTIVE, CLINICIAN- AND PATIENT-REPORTED EVALUATION OF LATE TOXICITY FOLLOWING ADJUVANT RADIATION IN EARLY BREAST CANCER: FOLLOW-UP RESULTS OF A RANDOMISED SERIES - FibroLate

Klinik für Strahlentherapie und Radioonkologie; Universitätsklinikum Bonn0 个研究点目标入组 100 人开始时间: 2022年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • breast-conserving surgery for breast cancer
  • - completion of a normofractionated or moderately hypofractionated radiation course without interruptions
  • - written informed consent

排除标准

  • - double-sided breast cancer (since the contralateral breast is used as an intrapatient control)
  • - mastectomy
  • - breast reconstruction with implant
  • - history of recurrent disease with ipsilateral re-lumpectomy or re-irradiation
  • - metastatic disease
  • - any preexisting dermatological disorders
  • - active dermatitis
  • - current treatment with topical or oral corticosteroids
  • - patient refusal to participate

研究者

发起方
Klinik für Strahlentherapie und Radioonkologie; Universitätsklinikum Bonn

相似试验